Published in Clin Chest Med on December 01, 2009
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med (2011) 6.42
Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev (2011) 3.63
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol (2011) 3.25
Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med (2011) 2.76
Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis (2011) 2.72
Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One (2010) 2.03
Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med (2011) 2.02
The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med (2011) 1.95
High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay. J Acquir Immune Defic Syndr (2012) 1.58
Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria. BMC Infect Dis (2012) 1.46
Current concepts in the management of tuberculosis. Mayo Clin Proc (2011) 1.36
Latent tuberculosis: what the host "sees"? Immunol Res (2011) 1.35
Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration. J Infect Dis (2011) 1.31
The impact of new tuberculosis diagnostics on transmission: why context matters. Bull World Health Organ (2012) 1.27
Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS (2012) 1.26
Comparison of the efficacies of loop-mediated isothermal amplification, fluorescence smear microscopy and culture for the diagnosis of tuberculosis. PLoS One (2011) 1.24
Evaluating tuberculosis case detection via real-time monitoring of tuberculosis diagnostic services. Am J Respir Crit Care Med (2011) 1.24
Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy. Expert Rev Anti Infect Ther (2011) 1.20
Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population. PLoS One (2011) 1.19
Effect of Diagnostic and Treatment Delay on the Risk of Tuberculosis Transmission in Shenzhen, China: An Observational Cohort Study, 1993-2010. PLoS One (2013) 1.16
Smear positive extra pulmonary tuberculosis disease at University of Gondar Hospital, Northwest Ethiopia. BMC Res Notes (2013) 1.06
Clinical research and development of tuberculosis diagnostics: moving from silos to synergy. J Infect Dis (2012) 1.03
Factors associated with latent tuberculosis among asylum seekers in Switzerland: a cross-sectional study in Vaud County. BMC Infect Dis (2012) 1.02
A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying Mycobacterium tuberculosis during routine clinical practice. J Thorac Dis (2014) 0.89
Comparison of four DNA extraction methods for detecting Mycobacterium tuberculosis by real-time PCR and its clinical application in pulmonary tuberculosis. J Thorac Dis (2013) 0.89
Initial experience with GeneXpert MTB/RIF assay in the Arkansas Tuberculosis Control Program. Australas Med J (2014) 0.88
Evaluation of Cepheid's Xpert MTB/Rif test on pleural fluid in the diagnosis of pleural tuberculosis in a high prevalence HIV/TB setting. PLoS One (2014) 0.85
Diagnosis of tuberculosis: the experience at a specialized diagnostic laboratory. J Negat Results Biomed (2011) 0.83
Host Protein Biomarkers Identify Active Tuberculosis in HIV Uninfected and Co-infected Individuals. EBioMedicine (2015) 0.82
Direct matrix-assisted laser desorption ionisation time-of-flight mass spectrometry identification of mycobacteria from colonies. Eur J Clin Microbiol Infect Dis (2016) 0.81
Challenges facing lipoarabinomannan urine antigen tests for diagnosing HIV-associated tuberculosis. Expert Rev Mol Diagn (2012) 0.78
Use of real time polymerase chain reaction for detection of M. tuberculosis, M. avium and M. kansasii from clinical specimens. BMC Infect Dis (2015) 0.77
GeneXpert MTB/RIF Testing in the Management of Patients with Active Tuberculosis; A Real Life Experience from Saudi Arabia. Infect Chemother (2014) 0.77
Vaccines for TB: Lessons from the Past Translating into Future Potentials. J Immunol Res (2015) 0.76
Efficacy and safety of recombinant Mycobacterium tuberculosis ESAT-6 protein for diagnosis of pulmonary tuberculosis: a phase II trial. Med Sci Monit (2013) 0.76
Evaluation of in-house polymerase chain reaction assay sensitivity, can it be utilized in limited-resources settings? Med J Islam Repub Iran (2014) 0.75
Screening strategies for active tuberculosis: focus on cost-effectiveness. Clinicoecon Outcomes Res (2016) 0.75
Tuberculosis diagnostics: Challenges and opportunities. Lung India (2012) 0.75
Combating Tuberculosis Infection: A Forbidding Challenge. Indian J Pharm Sci (2016) 0.75
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89
Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol (2009) 12.98
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med (2008) 9.49
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev (2013) 5.78
Diagnostics for the developing world. Nat Rev Microbiol (2004) 5.62
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet (2010) 4.71
Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis (2006) 4.63
Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings. J Clin Microbiol (2010) 4.54
Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest (2008) 4.41
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med (2011) 4.21
Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature (2006) 3.72
Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med (2012) 3.26
New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med (2010) 2.92
Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol (2007) 2.85
Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev (2014) 2.43
Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda. J Infect Dis (2013) 2.41
Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One (2009) 2.34
Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc Natl Acad Sci U S A (2010) 2.12
Major Mycobacterium tuberculosis lineages associate with patient country of origin. J Clin Microbiol (2009) 1.91
Mitochondrial DNA targets increase sensitivity of malaria detection using loop-mediated isothermal amplification. J Clin Microbiol (2010) 1.87
Clinical evaluation of a loop-mediated amplification kit for diagnosis of imported malaria. J Infect Dis (2013) 1.73
Robustness of a loop-mediated isothermal amplification reaction for diagnostic applications. FEMS Immunol Med Microbiol (2011) 1.71
Light-emitting diode technologies for TB diagnosis: what is on the market? Expert Rev Med Devices (2009) 1.70
Making malaria testing relevant: beyond test purchase. Trans R Soc Trop Med Hyg (2008) 1.67
Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. Clin Infect Dis (2010) 1.66
A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay. Am J Respir Crit Care Med (2011) 1.66
TB diagnostic tests: how do we figure out their costs? Expert Rev Anti Infect Ther (2009) 1.47
Diagnostic performance and costs of Capilia TB for Mycobacterium tuberculosis complex identification from broth-based culture in Bangkok, Thailand. Trop Med Int Health (2009) 1.46
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. Lancet Infect Dis (2013) 1.39
Diagnostic accuracy and reproducibility of WHO-endorsed phenotypic drug susceptibility testing methods for first-line and second-line antituberculosis drugs. J Clin Microbiol (2012) 1.32
An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection. Clin Infect Dis (2012) 1.31
An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia. PLoS One (2009) 1.27
Tuberculosis infection among young nursing trainees in South India. PLoS One (2010) 1.21
Performance of three LED-based fluorescence microscopy systems for detection of tuberculosis in Uganda. PLoS One (2010) 1.17
Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries. Clin Infect Dis (2008) 1.17
Diagnostics as essential tools for containing antibacterial resistance. Drug Resist Updat (2011) 1.12
Clinical research and development of tuberculosis diagnostics: moving from silos to synergy. J Infect Dis (2012) 1.03
Implications of storing urinary DNA from different populations for molecular analyses. PLoS One (2009) 1.00
Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients. J Infect Dis (2012) 0.96
High annual risk of tuberculosis infection among nursing students in South India: a cohort study. PLoS One (2011) 0.94
Admitting defeat. Int J Tuberc Lung Dis (2006) 0.90
Feasibility of magnetic bead technology for concentration of mycobacteria in sputum prior to fluorescence microscopy. BMC Infect Dis (2011) 0.88
Promise versus reality: optimism bias in package inserts for tuberculosis diagnostics. J Clin Microbiol (2012) 0.88
Tuberculosis and homelessness in Montreal: a retrospective cohort study. BMC Public Health (2011) 0.84
Tuberculosis and the city. Health Place (2009) 0.83
Operational implementation of LED fluorescence microscopy in screening tuberculosis suspects in an urban HIV clinic in Uganda. PLoS One (2013) 0.82
The Feasibility, Accuracy, and Impact of Xpert MTB/RIF Testing in a Remote Aboriginal Community in Canada. Chest (2015) 0.81
Expanding the role of the microscopic observation drug susceptibility assay in tuberculosis and HIV management. Clin Infect Dis (2010) 0.81
Cost-effectiveness comparison of Genechip and conventional drug susceptibility test for detecting multidrug-resistant tuberculosis in China. PLoS One (2013) 0.81
Transforming TB diagnosis: can patients and control programs afford to wait? Am J Trop Med Hyg (2012) 0.81
The BCG world atlas: a new, open-access resource for clinicians and researchers. Expert Rev Anti Infect Ther (2011) 0.77
Rapid diagnostics for influenza: what are the options? Future Microbiol (2010) 0.75
Ancient Disease, Modern Epidemiology: A Century of Progress in Understanding and Fighting Tuberculosis. Am J Epidemiol (2016) 0.75
Serologic Responses in Childhood Pulmonary Tuberculosis. Pediatr Infect Dis J (2017) 0.75